Gut Microbiota’s Role in Mood Disorders : Impact on Neurotransmitter Regulation, Neuroinflammation, and the Gut-Brain Axis.

Abstract 

In recent decades, there has been a growing realization of the effect of gut health and microbiota on mental health, particularly mood disorders. This paper aims to delve into the mechanisms through which gut microbiota affects mood disorders, focusing on the production and regulation of neurotransmitters. The primary objective of this paper is to investigate the role of gut microbiota on the development and severity of mood disorders. The secondary objectives include examining the mechanisms behind this link by exploring neurotransmitter regulation, neuroinflammation and the gut-brain axis. Through a comprehensive literature review, the studies by Jiang et al. (2015) and Cryan and Dinan (2012) were analyzed to provide evidence on the role of the gut-brain axis in mood regulation. The findings propose that gut-targeted therapies, such as dietary interventions or probiotics, show significant improvement in mood disorders by modulating and improving the communication between the gut and the brain. Furthermore, the paper highlights the need for a more holistic approach towards mental health treatment, considering the significant impact gut microbiota has on mood and behavior.

Gut microbiota 

The gut microbiota is a complex microbial community and a major gastrointestinal (GI) tract component. It is colonized by microorganisms from various taxonomies, including bacteria, archaea, fungi, and viruses. Research suggests that every individual human harbors approximately 10-100 million microbial cells in a symbiotic relationship (MacGill, 2018). The gut microbiota is essential in maintaining internal functions such as protection of the gastrointestinal barrier and metabolite digestion. These microorganisms ferment these substrates into short-chain fatty acids such as acetate, propionate, and butyrate, which serve as energy sources for colonocytes, absorptive cells found in the colon, and have anti-inflammatory properties (Frost et al., 2014). Disruption of the gut microbiota has been associated with several disorders, such as inflammatory bowel disease, obesity, metabolic syndrome, autism, and certain cancers (Behera et al., 2020). Furthermore, they help synthesize vitamins and aid in the development and function of the immune system. The gut microbiota regulates immune responses and promotes immune tolerance by protecting against pathogenic infections through competitive exclusion and the production of antimicrobial substances. 

The Gut-Brain Axis 

The gut-brain axis is a bidirectional neurohormonal communication system between the central and enteric nervous systems (ENS), linking the emotional and cognitive centers of the brain

with the peripheral intestinal functions (Carabotti et al., 2015). One of the primary components of the gut-brain axis is the enteric nervous system (ENS) which consists of a mesh-like system of neurons that work semi-independently from the Central Nervous System (CNS). These neurons regulate gastrointestinal functions like blood flow, motility, mucosal transport, and secretions. In addition to that, the vagus nerve, a key component of the parasympathetic nervous system, serves as a communication highway between the brain and gut, transmitting sensory and motor signals back and forth. The interaction of gut microbiota and the gut-brain axis occurs through neural, endocrine, immune, and humoral pathways, which can influence intestinal activities and, consequently, mood, cognition, and mental health (Appleton, 2018). 

The gut microbiome affects the brain through numerous pathways, such as stimulation of the vagus nerve, inducing metabolites of tryptophan, altering the HPA axis, microbial production of human neurotransmitters, and the stimulation of the immune system over higher permeability of gut epithelium (Gao et al. 2023). 

Therefore, the interplay of communication that takes place between these systems proves the profound impact that gut health can have on one's mental health and well-being, more specifically, mood disorders. 

Mood Disorders and Gut Health 

Mood disorders, or affective disorders, are characterized by persistent disturbances in mood and an impairment of daily functioning. For instance, Major Depressive Disorder (MDD) is a common yet serious mood disorder that is marked by prolonged feelings of sadness, hopelessness, sleeping problems (insomnia or sleeping too much), changes in appetite, and loss of interest in daily activities. Studies have shown that the gut microbiota plays a crucial role in influencing the development of mood disorders. Changes in the function and composition of the gut bacteria can lead to an alteration of brain chemistry and behavior. For example, animal models corroborated findings of gut dysbiosis and its relation to monoamine disruptions seen in clinical depression, correlating the gut microbiota with mood (Appleton, 2018). Probiotic and prebiotic interventions have shown improvements in alleviating the symptoms of depression, showcasing the potential of gut-targeted therapies (Yano et al., 2015). Understanding the chemical messengers that communicate information is essential to explore gut health’s influence on mood disorders. These neurotransmitters include serotonin, dopamine, and gamma-aminobutyric acid - all associated with mood regulation and mental health. 

Yano et al. (2015) found that enterochromaffin cells in the gut produce approximately 90% of the body’s serotonin. Serotonin is a neurotransmitter essential for numerous biological functions, touching on diverse functions like mood, reward, cognition, memory, and learning. Changes in the gut microbiota composition can impact serotonin production, influencing mood and behavior. Furthermore, studies have shown that specific strains of bacteria, Lactobacillus and Bifidobacterium, increase the production of tryptophan - a precursor of serotonin, leading to elevated levels of serotonin (Barret et al., 2012). Serotonin levels have been linked with depression, showcasing the role that gut microbiota has on mood disorders. Similarly, the production of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter important for slowing down the brain and initiating calming effects, occurs in the gut. Alterations in gut microbiota may lead to low levels of GABA, which is associated with anxiety disorders (Cryan & Dinan, 2012). Jiang et al. (2015) delved into the potential of probiotics, beneficial bacteria that enhance gut health, in alleviating the symptoms of depression and anxiety. The researchers carried out a controlled experiment where participants were administered specific strains of probiotics. The findings showed that supplementation of certain probiotic strains had a positive impact on depression and anxiety by modulating gut-brain axis signaling. The study also highlighted the role of probiotics in reducing gut inflammation. Chronic gut inflammation has been known to increase the permeability of the gut barrier, causing toxic/harmful substances to enter the bloodstream and reach the brain, potentially causing neuroinflammation. Neuroinflammation has been correlated with neurological and mood disorders. Moreover, probiotics also modulate the activity of the vagus nerve, resulting in improved communication between the gut and the brain. 

Cryan and Dinan (2015) further built upon the foundation laid by Jiang et al. by investigating the intricate relationship between diet and gut microbiota composition in the context of mood disorders. The study found that a fiber-rich diet encourages the growth of beneficial bacteria. These bacteria, in turn, produce short-chain fatty acids (SCFAs), chemicals that have anti-inflammatory properties and can cross the blood-brain barrier to modulate the immune system and reduce neuroinflammation by up to 40%. Moreover, the gut microbiota influences the HPA axis in multiple ways, such as by producing metabolites that impact stress hormones. For instance, SCFAs affect the release of corticotropin-releasing hormone (CRH), subsequently impacting the release of cortisol from the adrenal glands.

The study's findings showed that maintaining gut health reduces neuroinflammation, regulates neurotransmitter production, and improves HPA axis function. Since neuroinflammation has been linked with mood disorders, a clear correlation can be established between gut health and mental health. 

Conclusion 

In conclusion, the paper examined the role of gut microbiota in mental health and mood disorders, highlighting that disturbances in gut microbiota are closely linked with the development and exacerbation of mood disorders like depression and anxiety. The evidence discussed in the paper suggests that disruptions in gut microbiota can lead to altered neurotransmitter production, neuroinflammation and disturbances in the HPA axis - all factors that are associated in the development and worsening of mood disorders. Moreover, research by Jaing et al. (2015) and Cryan and Dinan (2012) provides evidence of the potential of gut-targeted therapies to improve symptoms of depression and anxiety. 

The studies discussed in this paper show evidence that gut health and mental health are directly linked, opening up avenues for therapeutic interventions. The potential for gut-microbiota-based therapies to regulate neurotransmitter production and modulate the HPA axis shows promise in managing and alleviating mood disorders. The growing understanding of this topic suggests the need for a more holistic approach towards mental health. Works cited

Appleton, J. (2018). The gut-brain axis: Influence of microbiota on mood and mental health. Integrative Medicine (Encinitas, Calif.), 17(4), 28–32. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469458/ 

Barrett, E., Ross, R. P., O'Toole, P. W., Fitzgerald, G. F., & Stanton, C. (2012). γ-Aminobutyric acid production by culturable bacteria from the human intestine. Journal of Applied Microbiology, 113(2), 411–417. https://doi.org/10.1111/j.1365-2672.2012.05344.x 

Behera, J., Ison, J., Tyagi, S. C., & Tyagi, N. (2020). The role of gut microbiota in bone homeostasis. Bone, 135, 115317. https://doi.org/10.1016/j.bone.2020.115317 

Carabotti, M., Scirocco, A., Maselli, M. A., & Severi, C. (2015). The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems. Annals of Gastroenterology, 28(2), 203–209. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367209/ 

Cenit, M. C., Sanz, Y., & Codoñer-Franch, P. (2017). Influence of gut microbiota on

neuropsychiatric disorders. World Journal of Gastroenterology, 23(30), 5486–5498. https://doi.org/10.3748/wjg.v23.i30.5486 

Dinan, T. G., & Cryan, J. F. (2017). Gut-brain axis in 2016: Brain-gut-microbiota axis - Mood, metabolism and behaviour. Nature Reviews Gastroenterology & Hepatology, 14(2), 69–70. https://doi.org/10.1038/nrgastro.2016.200 

Forsythe, P., Sudo, N., Dinan, T., Taylor, V. H., & Bienenstock, J. (2010). Mood and gut feelings. Brain, Behavior, and Immunity, 24(1), 9–16. https://doi.org/10.1016/j.bbi.2009.05.058 

Frost, G., Sleeth, M. L., Sahuri-Arisoylu, M., Lizarbe, B., Cerdan, S., Brody, L., ... & Bell, J. D. (2014). The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nature Communications, 5, 3611. 

Gao, M., Wang, J., Liu, P., Tu, H., Zhang, R., Zhang, Y., Sun, N., & Zhang, K. (2023). Gut microbiota composition in depressive disorder: A systematic review, meta-analysis, and meta-regression. Translational Psychiatry, 13(1). https://doi.org/10.1038/s41398-023-02670-5 

Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., ... & Ruan, B. (2015). Altered fecal microbiota composition in patients with major depressive disorder. Brain, Behavior, and Immunity, 48, 186-194. https://doi.org/10.1016/j.bbi.2015.03.016 

Lucas, G. (2018). Gut thinking: The gut microbiome and mental health beyond the head. Microbial Ecology in Health and Disease, 29(2). 

https://doi.org/10.1080/16512235.2018.1548250

MacGill, M. (2018, June 26). What are the gut microbiota and human microbiome? Medical News Today. https://www.medicalnewstoday.com/articles/307998 

Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021). The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacological Research, 172, 105840. https://doi.org/10.1016/j.phrs.2021.105840 

Thakur, A. K., Shakya, A., Husain, G. M., Emerald, M., & Kumar, V. (2014). Gut-microbiota and mental health: Current and future perspectives. Journal of Pharmacology and Clinical Toxicology, 2(1), 1016. 

Yano, J. M., Yu, K., Donaldson, G. P., Shastri, G. G., Ann, P., Ma, L., ... & Hsiao, E. Y. (2015). Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell, 161(2), 264-276. Written By: Aarna Sharma